1 / 6

Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma

Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma September 18, 2003 Elizabeth Callaghan Division of Blood Applications Revisions to Labeling and Storage Proposed rule published July 30, 2003 Main objectives:

paul2
Télécharger la présentation

Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma September 18, 2003 Elizabeth Callaghan Division of Blood Applications

  2. Revisions to Labeling and Storage • Proposed rule published July 30, 2003 • Main objectives: • Consolidate, simplify, and update container labels and instruction circular regulations • Remove inconsistencies with ISBT 128 • Modify shipping and storage temperatures for frozen noncellular products

  3. Revisions to Labeling and Storage • Combined both WB and SP labeling requirements into one section of the CFR • “shall” to “must” • Registration/license number to “unique facility identifier” • Anticoagulant no longer has to precede proper name

  4. Revisions to Labeling and Storage • SP storage temp changed from –20 C to –30 C • SP shipping temp changed to –15C • FFP/Cryo • Storage temp • -18 to -25 3 month expiration • -25 or colder 2 year expiration • Shipping temp • Same as storage

  5. Revisions to Labeling and Storage • Comments due by 10/28/03 • Sent to: • Division of Dockets Management (HFA-305) • FDA • 5630 Fishers Lane, Rm 1061 • Rockville, MD 20852 • Or • www.fda.gov/dockets/ecomments • Docket No. 2003N-0211

  6. Revisions to Labeling and Storage • Changed testing statement to include all required testing not just HIV, HBV and Syphilis • Testing statement on recovered plasma • Du to weak D

More Related